Citi maintains Ascendis Pharma stock at Buy, positive outlook ahead of pivotal trial data

Tomas Kauer - Moderator

Sep 10, 2024 - 22:00

0

Citi maintains Ascendis Pharma stock at Buy, positive outlook ahead of pivotal trial data

Tags:

Previous Article

EU's Vestager triumphs in crackdown on Apple's tax deal, Google's practices

Rubrik stock shines with raised guidance and strong cloud growth

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator www.tomaskauer.com

Related Posts

Beta Technologies unveils first passenger carrying electric aircraft

Beta Technologies unveils first passenger carrying elec...

Tomas Kauer - Mode... Oct 1, 2024 0

South Korea market watchdog highlights pension fund's role in market reforms

South Korea market watchdog highlights pension fund's r...

Tomas Kauer - Mode... Sep 12, 2024 0

Plaud’s $169 ChatGPT&powered NotePin has a permanent place in my travel bag

Plaud’s $169 ChatGPT&powered NotePin has a permanent pl...

Tomas Kauer - Mode... Sep 21, 2024 0